All Stories

  1. Biomarkers in acute kidney injury (AKI )
  2. Serum creatinine and cystatin C provide conflicting evidence of acute kidney injury following acute ingestion of potassium permanganate and oxalic acid
  3. The Role of Nephrologist in the Intensive Care Unit
  4. A comprehensive renal vascular access clinic results in improved patient outcomes and reduced costs
  5. Mechanism-specific injury biomarkers predict nephrotoxicity early following glyphosate surfactant herbicide (GPSH) poisoning
  6. Bench to bedside: the next steps for biomarkers in acute kidney injury
  7. Unlocking the code: mining the urinary proteome after renal transplantation
  8. Timely Diagnosis of Acute Kidney Injury Using Kinetic eGFR and the Creatinine Excretion to Production Ratio, E/eG - Creatinine Can Be Useful!
  9. Biomarkers of drug-induced acute kidney injury in the adult
  10. Kidney damage biomarkers detect acute kidney injury but only functional markers predict mortality after paraquat ingestion
  11. Evaluation of biomarkers of cell cycle arrest and inflammation in prediction of dialysis or recovery after kidney transplantation
  12. Beware the dog that didn't bark: a tale of creatinine in acute kidney injury
  13. Perioperative change in creatinine following cardiac surgery with cardiopulmonary bypass is useful in predicting acute kidney injury: a single-centre retrospective cohort study
  14. Removal of body surface area normalisation improves raw-measured glomerular filtration rate estimation by the Chronic Kidney Disease Epidemiology Collaboration equation and drug dosing in the obese
  15. Role of biomarkers of nephrotoxic acute kidney injury in deliberate poisoning and envenomation in less developed countries
  16. Kinetic Estimation of GFR Improves Prediction of Dialysis and Recovery after Kidney Transplantation
  17. Fab fragments of ovine antibody to colchicine enhance its clearance in the rat
  18. Mechanisms Underlying Early Rapid Increases in Creatinine in Paraquat Poisoning
  19. Clusterin in Kidney Transplantation
  20. A Randomized, Placebo-Controlled Trial of Pentoxifylline on Erythropoiesis-Stimulating Agent Hyporesponsiveness in Anemic Patients With CKD: The Handling Erythropoietin Resistance With Oxpentifylline (HERO) Trial
  21. Comparative performances of the new chronic kidney disease epidemiology equations incorporating cystatin C for use in cancer patients
  22. Novel biomarkers of acute kidney injury: time for implementation?
  23. Biomarkers of calcineurin inhibitor nephrotoxicity in transplantation
  24. The clinical utility window for acute kidney injury biomarkers in the critically ill
  25. Acute kidney injury: Cell cycle arrest biomarkers win race for AKI diagnosis
  26. Recovery from Acute Kidney Injury: The Role of Biomarkers
  27. Using Biomarkers for Acute Kidney Injury: Barriers and Solutions
  28. Lean mass modulates glomerular filtration rate in males of normal and extreme body composition
  29. Acute Kidney Injury Urinary Biomarker Time-Courses
  30. A Comparison of the Ability of Levels of Urinary Biomarker Proteins and Exosomal mRNA to Predict Outcomes after Renal Transplantation
  31. KHA-CARI guideline: KHA-CARI adaptation of the KDIGO Clinical Practice Guideline for Acute Kidney Injury
  32. Kidney biomarkers in MCPA-induced acute kidney injury in rats: Reduced clearance enhances early biomarker performance
  33. Potential use of biomarkers in acute kidney injury: report and summary of recommendations from the 10th Acute Dialysis Quality Initiative consensus conference
  34. Use of a glyphosate-based herbicide-induced nephrotoxicity model to investigate a panel of kidney injury biomarkers
  35. Acute kidney injury: Late-onset acute kidney injury—subacute or more of the same?
  36. Renal biomarkers predict nephrotoxicity after paraquat
  37. Biomarkers and creatinine in AKI: the trough of disillusionment or the slope of enlightenment?
  38. Acute kidney injury: an increasing global concern
  39. Clinical use of biomarkers for toxicant-induced acute kidney injury
  40. High-dose intravenous epoetin does not increase blood pressure in critically ill patients with acute kidney injury
  41. Linking Injury to Outcome in Acute Kidney Injury: A Matter of Sensitivity
  42. Differential Diagnosis of AKI in Clinical Practice by Functional and Damage Biomarkers: Workgroup Statements from the Tenth Acute Dialysis Quality Initiative Consensus Conference
  43. Cellular Mechanisms of Drug Nephrotoxicity
  44. The Clinical Utility of Plasma Neutrophil Gelatinase-Associated Lipocalin in Acute Kidney Injury
  45. The urine output definition of acute kidney injury is too liberal
  46. Combining creatinine and volume kinetics identifies missed cases of acute kidney injury following cardiac arrest
  47. Implementation of Novel Biomarkers in the Diagnosis, Prognosis, and Management of Acute Kidney Injury: Executive Summary from the Tenth Consensus Conference of the Acute Dialysis Quality Initiative (ADQI)
  48. The relative effects of fat versus muscle mass on cystatin C and estimates of renal function in healthy young men
  49. Explaining new methods to assess the added value of a biomarker
  50. Some biomarkers of acute kidney injury are increased in pre-renal acute injury
  51. Acute kidney injury clinical trial design: old problems, new strategies
  52. Four hour creatinine clearance is better than plasma creatinine for monitoring renal function in critically ill patients
  53. Test Characteristics of Urinary Biomarkers Depend on Quantitation Method in Acute Kidney Injury
  54. Trientine and renin-angiotensin system blockade ameliorate progression of glomerular morphology in hypertensive experimental diabetic nephropathy
  55. Renal ischemic preconditioning: finally some good news for prevention of acute kidney injury
  56. Clearance and beyond: the complementary roles of GFR measurement and injury biomarkers in acute kidney injury (AKI)
  57. Was It the Nephrologists or the Fluid?
  58. Albuminuria increases cystatin C excretion: implications for urinary biomarkers
  59. Improved performance of urinary biomarkers of acute kidney injury in the critically ill by stratification for injury duration and baseline renal function
  60. Baseline creatinine: where to from here?
  61. Modelling acute renal failure using blood and breath biomarkers in rats
  62. Predictor of Early Diagnosis, Diagnosis, or Progression of Acute Kidney Injury
  63. Breath ammonia and trimethylamine allow real-time monitoring of haemodialysis efficacy
  64. Renal autoregulation and passive pressure-flow relationships in diabetes and hypertension
  65. Ochroconis gallopava peritonitis in a cardiac transplant patient on continuous ambulatory peritoneal dialysis
  66. Early intervention with erythropoietin does not affect the outcome of acute kidney injury (the EARLYARF trial)
  67. Back-Calculating Baseline Creatinine with MDRD Misclassifies Acute Kidney Injury in the Intensive Care Unit
  68. Differential contribution of diabetes and the Ren2 gene to glomerular pathology in diabetic (mREN-2)27 rats
  69. Rapid detection of acute kidney injury by plasma cystatin C in the intensive care unit
  70. New and better biomarkers of acute kidney injury
  71. Urinary cystatin C is diagnostic of acute kidney injury and sepsis, and predicts mortality in the intensive care unit
  72. Secondary prevention of acute kidney injury
  73. Outcome definitions in non-dialysis intervention and prevention trials in acute kidney injury (AKI)
  74. Evaluation of Trial Outcomes in Acute Kidney Injury by Creatinine Modeling
  75. Characterization of NT-proBNP in Human Urine
  76. GFR shot by RIFLE: errors in staging acute kidney injury
  77. RIFLE and AKIN - maintain the momentum and the GFR!
  78. Modelling Acute Renal Failure using Blood and Breath Biomarkers in Rats
  79. Acute Kidney Injury: Definitions and New Paradigms
  80. Dynamic myogenic autoregulation in the rat kidney: a whole-organ model
  81. Corrigendum
  82. Early detection of acute kidney injury: Emerging new biomarkers (Review Article)
  83. Classifying algorithms for SIFT-MS technology and medical diagnosis
  84. Cellular Mechanisms of Drug Nephrotoxicity
  85. Animal models for the assessment of acute renal dysfunction and injury
  86. Classification Algorithms for SIFT-MS Medical Diagnosis
  87. Nephrogenic systemic fibrosis: is any contrast safe in renal failure?
  88. Administration of erythropoietin and its derivatives in renal disease: Advantages, mechanisms and concerns
  89. Renal endothelial dysfunction and impaired autoregulation after ischemia-reperfusion injury result from excess nitric oxide
  90. Delayed administration of darbepoetin or erythropoietin protects against ischemic acute renal injury and failure
  91. Subcutaneous gas tensions closely track ileal mucosal gas tensions in a model of endotoxaemia without anaerobism
  92. Role of protein kinase C and oxidative stress in interleukin-1beta-induced human proximal tubule cell injury and fibrogenesis
  93. Angiotensin II facilitates autoregulation in the perfused mouse kidney: An optimized in vitro model for assessment of renal vascular and tubular function
  94. Erythropoietin protects against ischaemic acute renal injury
  95. MR microscopy and microspectroscopy of the intact kidney
  96. Facilitation of renal autoregulation by angiotensin II is mediated through modulation of nitric oxide
  97. Cell death in toxic nephropathies
  98. Measurement of tubular enzymuria facilitates early detection of acute renal impairment in the intensive care unit
  99. Sodium crocetinate does not alter gut hypercapnic responses or renal energy stores during transient sub-diaphragmatic ischaemia
  100. Animal models for the assessment of acute renal dysfunction and injury
  101. ATP-Dependent K+Channels in Renal Ischemia Reperfusion Injury
  102. In vivo andin vitro models demonstrate a role for caveolin-1 in the pathogenesis of ischaemic acute renal failure
  103. Repetitive Brief Ischemia: Intermittent Reperfusion During Ischemia Ameliorates the Extent of Injury in the Perfused Kidney
  104. Interleukin-1β stimulates human renal fibroblast proliferation and matrix protein production by means of a transforming growth factor-β-dependent mechanism
  105. Interleukin-1β induces human proximal tubule cell injury, α-smooth muscle actin expression and fibronectin production1
  106. Interacting Roles of Myofibroblasts, Apoptosis and Fibrogenic Growth Factors in the Pathogenesis of Renal Tubulo-interstitial Fibrosis
  107. Treatment of lupus nephritis: art or science?
  108. Reversal of cardiac and renal fibrosis by pirfenidone and spironolactone in streptozotocin-diabetic rats
  109. Bcl-XL translocation in renal tubular epithelial cells in vitro protects distal cells from oxidative stress
  110. Renal impairment in deoxycorticosterone acetate‐salt hypertensive rats
  111. Escape from Apoptosis after Prolonged Serum Deprivation Is Associated with the Regulation of the Mitochondrial Death Pathway by Bcl-
  112. RELATIONSHIP BETWEEN MYOFIBROBLAST APOPTOSIS AND GROWTH FACTORS IN THE PATHOGENESIS OF RENAL TUBULOINTERSTITIAL FIBROSIS
  113. Accuracy of base excess—An in vitro evaluation of the Van Slyke equation
  114. Accuracy of intramucosal pH calculated from arterial bicarbonate and the Henderson-Hasselbalch equation: Assessment using simulated ischemia
  115. Cell survival or death in renal tubular epithelium after ischemia-reperfusion injury
  116. Bcl-2 genes and growth factors in the pathology of ischaemic acute renal failure
  117. DNA fragmentation reduced by antioxidants following ischaemia-reperfusion in the isolated perfused rat kidney
  118. Magnetic resonance imaging and spectroscopy in critical care nephrology
  119. Continuous measurement of gut luminal PCO sub 2 in the rat
  120. Serine isotopomer analysis by 13C-NMR defines glycine-serine interconversion in situ in the renal proximal tubule
  121. Modulation of glycine-serine interconversion by TCA and glycolytic intermediates in normoxic and hypoxic proximal tubules
  122. Detection of Hydroxyl and Carbon-Centred Radicals by EPR Spectroscopy after Ischaemia and Reperfusion of the Rat Kidney
  123. Anatomical and functional imaging of transplant acute renal failure
  124. Hydroxyl radical generation following ischaemia-reperfusion in cell-free perfused rat kidney
  125. Renal glomerular lesions in unselected patients with cirrhosis undergoing orthotopic liver transplantation
  126. 23Na NMR Detects Protection by Glycine and Alanine Against Hypoxic Injury in the Isolated Perfused Rat Kidney
  127. 23Na-NMR detects hypoxic injury in intact kidney: Increases in sodium inhibited by DMSO and DMTU
  128. Non-linear regression and variance ratio analysis of time based NMR data
  129. Glomerular abnormalities in children undergoing orthotopic liver transplantation
  130. Universal Occurrence of Glomerular Abnormalities in Patients Receiving Liver Transplants
  131. Acute Lowering of Plasma Oncotic Pressure Increases Filtration Fraction and Sodium Excretion in Conscious Sheep
  132. Skin cancer in renal transplant recipients
  133. Toxicity of dysprosium shift reagents in the isolated perfused rat kidney
  134. 87-Rubidium NMR: A novel method of measuring cation flux in intact kidney
  135. 31 P, 87 Rb and 23 Na studies of the perfused rat kidney
  136. Renal Nuclear Magnetic Resonance
  137. The Isolated Perfused Rat Kidney: Filtering and Non-Filtering Models in the Assessment of Altered Renal Vascular Resistance in Nephrotoxicity
  138. Erythrocytes alter the pattern of renal hypoxic injury: predominance of proximal tubular injury with moderate hypoxia
  139. 87Rb, 23Na and P Nuclear Magnetic Resonance Spectroscopy of the Perfused Rat Kidney
  140. Ischaemic Acute Renal Failure: Why Does It Occur?
  141. Differentiation between intra- and extra-cellular components of renal 87 Rb nuclear-magnetic-resonance spectra by lineshape analysis
  142. Nuclear magnetic resonance studies of 87 Rb + transport in perfused rat kidney
  143. Viscosity of concentrated solutions and of human erythrocyte cytoplasm determined from NMR measurement of molecular correlation times The dependence of viscosity on cell volume
  144. Proton NMR spectroscopy of rabbit renal cortex
  145. C3 metabolism in acute glomerulonephritis: Implications for sites of complement activation
  146. Cell volume dependence of 1H spin-echo NMR signals in human erythrocyte suspensions
  147. SUCCESSFUL TREATMENT OF ACUTE DAPSONE INTOXICATION USING CHARCOAL HEMOPERFUSION
  148. Faculty of 1000 evaluation for Renal recovery.
  149. Faculty of 1000 evaluation for Thyroid hormones for acute kidney injury.
  150. Volume Localised1H MRS of Renal Osmolytes
  151. Faculty of 1000 evaluation for Prevention of contrast-induced acute kidney injury: is simple oral hydration similar to intravenous? A systematic review of the evidence.
  152. Faculty of 1000 evaluation for Rasburicase in tumor lysis syndrome of the adult: a systematic review and meta-analysis.
  153. Faculty of 1000 evaluation for Preoperative Estimates of Glomerular Filtration Rate as Predictors of Outcome after Surgery: A Systematic Review and Meta-analysis.
  154. Faculty of 1000 evaluation for Intravenous N-acetylcysteine for prevention of contrast-induced nephropathy: a meta-analysis of randomized, controlled trials.
  155. Faculty of 1000 evaluation for Early acid-base and blood pressure effects of continuous renal replacement therapy intensity in patients with metabolic acidosis.
  156. Faculty of 1000 evaluation for Prophylactic perioperative sodium bicarbonate to prevent acute kidney injury following open heart surgery: a multicenter double-blinded randomized controlled trial.
  157. Faculty of 1000 evaluation for Ischemic Preconditioning for Prevention of Contrast-Medium-Induced Nephropathy: Randomized Pilot RenPro-Trial (Renal Protection Trial).
  158. Faculty of 1000 evaluation for Health-Related Quality of Life as a Predictor of Mortality among Survivors of AKI.
  159. Faculty of 1000 evaluation for Performance of Urinary Liver-Type Fatty Acid-Binding Protein in Acute Kidney Injury: A Meta-analysis.
  160. Faculty of 1000 evaluation for Clinical review: volume of fluid resuscitation and the incidence of acute kidney injury - a systematic review.
  161. Faculty of 1000 evaluation for Increased risk of death and de novo chronic kidney disease following reversible acute kidney injury.
  162. Faculty of 1000 evaluation for Sodium chloride vs. sodium bicarbonate for the prevention of contrast medium-induced nephropathy: a randomized controlled trial.
  163. Faculty of 1000 evaluation for Randomized Controlled Trial of Sirolimus Conversion in Cardiac Transplant Recipients With Renal Insufficiency.
  164. Faculty of 1000 evaluation for Does the surface-treated AN69 membrane prolong filter survival in CRRT without anticoagulation?
  165. Faculty of 1000 evaluation for Sodium bicarbonate infusion to reduce cardiac surgery-associated acute kidney injury: a phase II multicenter double-blind randomized controlled trial.
  166. Faculty of 1000 evaluation for Sustained low efficiency dialysis using a single-pass batch system in acute kidney injury - a randomized interventional trial: the REnal Replacement Therapy Study in Intensive Care Unit PatiEnts.
  167. Faculty of 1000 evaluation for Effect of a Buffered Crystalloid Solution vs Saline on Acute Kidney Injury Among Patients in the Intensive Care Unit: The SPLIT Randomized Clinical Trial.